Literature DB >> 6373562

Hepatitis B virus and myocarditis.

P C Ursell, A Habib, P Sharma, R Mesa-Tejada, J H Lefkowitch, J J Fenoglio.   

Abstract

Myocarditis may be a serious extrahepatic complication of hepatitis. In this fatal case of serologically documented hepatitis B viral hepatitis, acute myocarditis was present, with histologic features consistent with a viral pathogenesis. Hepatitis B surface antigen was demonstrated by immunoperoxidase methods in small intramyocardial vessels, suggesting that hepatitis B virus infected the heart. The resulting inflammatory heart disease may have been caused either directly, by virus infecting the myocardium, or indirectly, by an immune-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373562     DOI: 10.1016/s0046-8177(84)80085-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

Review 1.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 2.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

3.  Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells.

Authors:  Qifei Rong; Jun Huang; Enben Su; Jun Li; Jianyong Li; Lili Zhang; Kejiang Cao
Journal:  Virol J       Date:  2007-04-02       Impact factor: 4.099

4.  Acute Myopericarditis After First Dose of mRNA-1273 SARS-CoV-2 Vaccine in a Young Adult.

Authors:  Kahtan Fadah; Mehran Abolbashari; Chandra Ojha; Haider Alkhateeb
Journal:  Cureus       Date:  2022-02-11

5.  Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta.

Authors:  Minmin Yu; Qian Jiang; Xiaojun Gu; Lili Ju; Ying Ji; Kaihua Wu; Hongxiu Jiang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.